Species differences in renal gamma-glutamyl transpeptidase activity do not correlate with susceptibility to 2-bromo-(diglutathion-S-yl)-hydroquinone nephrotoxicity.

[1]  T. Monks,et al.  Oxidative cyclization, 1,4-benzothiazine formation and dimerization of 2-bromo-3-(glutathion-S-yl)hydroquinone. , 1990, Molecular pharmacology.

[2]  T. Monks,et al.  Glutathione, gamma-glutamyl transpeptidase, and the mercapturic acid pathway as modulators of 2-bromohydroquinone oxidation. , 1990, Toxicology and applied pharmacology.

[3]  T. Monks,et al.  The in vivo disposition of 2-bromo-[14C]hydroquinone and the effect of gamma-glutamyl transpeptidase inhibition. , 1990, Toxicology and applied pharmacology.

[4]  G. Siest,et al.  Electrophoretic mobility of gamma-glutamyltransferase in rat liver subcellular fractions. Evidence for structure difference from the kidney enzyme. , 1989, The Biochemical journal.

[5]  R. Schnellmann,et al.  2-Bromohydroquinone-induced toxicity to rabbit renal proximal tubules: the role of biotransformation, glutathione, and covalent binding. , 1989, Toxicology and applied pharmacology.

[6]  T. Higashi,et al.  Comparative study of the sugar chains of gamma-glutamyltranspeptidases purified from human hepatocellular carcinoma and from human liver. , 1989, Journal of biochemistry.

[7]  T. Monks,et al.  Sequential oxidation and glutathione addition to 1,4-benzoquinone: correlation of toxicity with increased glutathione substitution. , 1988, Molecular pharmacology.

[8]  N. Heisterkamp,et al.  Cloning and nucleotide sequence of human gamma-glutamyl transpeptidase. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[9]  G. Prota Progress in the chemistry of melanins and related metabolites , 1988, Medicinal research reviews.

[10]  T. Monks,et al.  2-Bromo-(diglutathion-S-yl)hydroquinone nephrotoxicity: physiological, biochemical, and electrochemical determinants. , 1988, Molecular pharmacology.

[11]  G. Guellaen,et al.  gamma-Glutamyl transpeptidase: a single copy gene in the rat and a multigene family in the human genome. , 1988, The Journal of biological chemistry.

[12]  T. Monks,et al.  Synthesis and nephrotoxicity of 6-bromo-2,5-dihydroxy-thiophenol. , 1988, Molecular pharmacology.

[13]  S. Tate,et al.  Renal gamma-glutamyl transpeptidases: structural and immunological studies. , 1988, Archives of biochemistry and biophysics.

[14]  T. Monks,et al.  Co-oxidation of 2-bromohydroquinone by renal prostaglandin synthase. Modulation of prostaglandin synthesis by 2-bromohydroquinone and glutathione. , 1987, Drug metabolism and disposition: the biological fate of chemicals.

[15]  E. Lock,et al.  Effect of the organic acid transport inhibitor probenecid on renal cortical uptake and proximal tubular toxicity of hexachloro-1,3-butadiene and its conjugates. , 1985, Toxicology and applied pharmacology.

[16]  T. Monks,et al.  Glutathione conjugates of 2-bromohydroquinone are nephrotoxic. , 1985, Drug metabolism and disposition: the biological fate of chemicals.

[17]  T. Monks,et al.  Identification of 2-bromohydroquinone as a metabolite of bromobenzene and o-bromophenol: implications for bromobenzene-induced nephrotoxicity. , 1984, The Journal of pharmacology and experimental therapeutics.

[18]  T. Monks,et al.  Formation of nontoxic reactive metabolites of p-bromophenol. Identification of a new glutathione conjugate. , 1984, Drug metabolism and disposition: the biological fate of chemicals.

[19]  J. Newton,et al.  Nephrotoxicity of phenolic bromobenzene metabolites in the mouse. , 1984, Toxicology.

[20]  E. Lock,et al.  The metabolism and disposition of hexachloro-1:3-butadiene in the rat and its relevance to nephrotoxicity. , 1984, Toxicology and applied pharmacology.

[21]  G. Weber Biochemical strategy of cancer cells and the design of chemotherapy: G. H. A. Clowes Memorial Lecture. , 1983, Cancer research.

[22]  D. J. Reed,et al.  The binding mechanism of glutathione and the anti-tumor drug L-(αS.5S)-α-amino-3-chloro-4.5-dihydro-5-isoxazoleacetic acid (AT-125; NSC-163501) to γ-glutamyltransferase , 1983 .

[23]  M. Duffel,et al.  Cysteine S-conjugate N-acetyltransferase from rat kidney microsomes. , 1982, Molecular pharmacology.

[24]  M. Tateishi,et al.  Purification and characterization of a rat liver enzyme catalyzing N-deacetylation of mercapturic acid conjugates. , 1981, Drug metabolism and disposition: the biological fate of chemicals.

[25]  D. J. Reed,et al.  The inhibition of γ-glutamyl transpeptidase and glutathione metabolism of isolated rat kidney cells by L-(αS, 5S)-α-amino-3-chloro-4, 5-dihydro-5-isoxazoleacetic acid (AT-125; NSC-163501) , 1980 .

[26]  B. Kaissling,et al.  Structural analysis of the rabbit kidney. , 1979, Advances in anatomy, embryology, and cell biology.

[27]  M. Ross,et al.  Human kidney gamma-glutamyl transpeptidase. Catalytic properties, subunit structure, and localization of the gamma-glutamyl binding site on the light subunit. , 1977, The Journal of biological chemistry.

[28]  A. Meister,et al.  Interaction of gamma-glutamyl transpeptidase with amino acids, dipeptides, and derivatives and analogs of glutathione. , 1974, The Journal of biological chemistry.

[29]  W. D. Reid Mechanism of renal necrosis induced by bromobenzene , 1973 .

[30]  B. Brodie,et al.  Bromobenzene-induced hepatic necrosis: species differences and protection by SKF 525-A. , 1971, Research communications in chemical pathology and pharmacology.

[31]  A. B. Maunsbach Observations on the segmentation of the proximal tubule in the rat kidney. Comparison of results from phase contrast, fluorescence and electron microscopy. , 1966, Journal of ultrastructure research.

[32]  T. Franklin,et al.  The formation of mercapturic acids. 3. N-Acetylation of S-substituted cysteines in the rabbit, rat and guinea pig. , 1959, The Biochemical journal.

[33]  T. Monks,et al.  Glutathione conjugation as a mechanism of targeting latent quinones to the kidney. , 1991, Advances in experimental medicine and biology.

[34]  A. Yunis,et al.  The inhibition of gamma-glutamyl transpeptidase from human pancreatic carcinoma cells by (alpha S,5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (AT-125; NSC-163501). , 1980, Research communications in chemical pathology and pharmacology.

[35]  S. Tate Chapter 5 – Enzymes of Mercapturic Acid Formation , 1980 .

[36]  D. Parke,et al.  Biological Reactive Intermediates , 1977, Springer US.